A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. (Q53315710)

13 May 2018

title

A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. (English)

1 reference

13 May 2018

1 reference

13 May 2018

Kari Hemminki

Kari Hemminki

1 reference

13 May 2018

Barbara Wappenschmidt

Barbara Wappenschmidt

1 reference

13 May 2018

Alfons Meindl

1 reference

13 May 2018

Rita K Schmutzler

1 reference

13 May 2018

Barbara Burwinkel

1 reference

13 May 2018

Peter Bugert

1 reference

13 May 2018

Sandrine Tchatchou

Sandrine Tchatchou

1 reference

13 May 2018

Nina Ditsch

Nina Ditsch

1 reference

13 May 2018

Raymonda Varon-Mateeva

Raymonda Varon-Mateeva

1 reference

13 May 2018

author name string

Anke Jung

1 reference

13 May 2018

Christian Sutter

1 reference

13 May 2018

Bernhard H F Weber

1 reference

13 May 2018

Dieter Niederacher

1 reference

13 May 2018

Claus R Bartram

1 reference

13 May 2018

language of work or name

English

0 references

publication date

20 November 2008

1 reference

13 May 2018

published in

Carcinogenesis

1 reference

13 May 2018

volume

1 reference

13 May 2018

issue

1 reference

13 May 2018

page(s)

59-64

1 reference

13 May 2018

Mechanisms of gene silencing by double-stranded RNA

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

MicroRNAs in vertebrate development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Camels and zebrafish, viruses and cancer: a microRNA update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Sizing up miRNAs as cancer genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

MicroRNA-cancer connection: the beginning of a new tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

MicroRNA biogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

21 January 2018

MicroRNAs as oncogenes

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

MicroRNAs in cell proliferation, cell death, and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Elucidation of the small RNA component of the transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Endogenous human microRNAs that suppress breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Natural selection on human microRNA binding sites inferred from SNP data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Sequence variants in SLITRK1 are associated with Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Epidemiology of cancer: global patterns and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Epidemiology of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

The genetics and genomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Role of Src expression and activation in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

The role of estrogen in mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Hormone dependence of mammary tumors induced in rats by intraperitoneal NMU injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

New approaches to the endocrine prevention and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Endocrine-responsive breast cancer and strategies for combating resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Amplification studies of MET and Cdk6 in a rat endometrial tumor model and their correlation to human type I endometrial carcinoma tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Transcriptional activation of the nuclear receptor corepressor RIP140 by retinoic acid: a potential negative-feedback regulatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

p21-activated kinase signaling in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

AR and ER interaction with a p21-activated kinase (PAK6)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

TGF-alpha-driven tumor growth is inhibited by an EGF receptor tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Targeting TACE-dependent EGFR ligand shedding in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Association of NCOA3 polymorphisms with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

ESR1 and EGF genetic variation in relation to breast cancer risk and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Estrogen receptor genotypes and haplotypes associated with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Estrogen receptor alpha polymorphisms and postmenopausal breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Estrogen receptors: how do they signal and what are their targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Nuclear receptors in disease: the oestrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Hormonal influences on cancer progression and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Proximal 6q, a region showing allele loss in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

The role of the estrogen receptor in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Estrogen receptor variants in clinical breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

A common coding variant in CASP8 is associated with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN253

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGN253

1 reference

13 May 2018

1 reference

13 May 2018